Thomas Bersot, MD, PhD
Director of the Gladstone Lipid Clinic, Associate Investigator, Gladstone Institute of Cardiovascular Disease, and Research Integrity Officer

Other Professional Titles

Director of the Gladstone Lipid Clinic, Professor of Medicine, University of California, San Francisco


(415) 734-2027


(415) 355-0919


Gayatri Saldivar
(415) 734-2026

On The Web

Areas of Investigation

My work focuses on managing and teaching about heart disease and stroke prevention. Studies of lipid metabolism, at Gladstone and elsewhere, have provided insights and expertise that are applied to caring for patients with plasma cholesterol levels that are difficult to manage. This expertise is communicated to healthcare providers and the community through my Gladstone Outreach Program. The Outreach Program includes patient care, teaching, and research related to blood lipid (cholesterol) disorders and preventing coronary heart disease (CHD). Patient care is delivered through the Gladstone Lipid Clinic. This clinic also houses the Gladstone Lipid Disorders Training Center, which serves as a demonstration and educational program for students, residents, and fellows of the UCSF Schools of Medicine and Pharmacy, as well as for other postgraduate healthcare professionals. In addition, the Gladstone Lipid Clinic offers courses for postgraduate physicians in the Lipid Disorders Training Center. This center offers a 2 1/2 day mini-fellowship for those seeking comprehensive knowledge about managing cardiovascular risk factors. A highlight of these mini-fellowships is a one-day demonstration clinic during which course participants see 8–10 patients in the Gladstone Lipid Clinic. The Center also offers one-day update courses, which provide guidance about managing patients based on recent advances in basic and clinical science. My experience in clinical research led to my interest in the ethical conduct and treatment of patients participating in clinical research. Currently, I chair one of four ethics panels that review all clinical research protocols conducted at the University of California, San Francisco (UCSF), including those by investigators at Gladstone.

Lab Focus

Managing the treatment of patients with difficult problems in lipid metabolism.
Training healthcare providers in the best ways to manage lipid metabolism.


Delineated the liver’s role in forming lipoproteins prior to their secretion into the blood.
Identified apoE as a ligand of the low-density lipoprotein receptor.
Initiated the lipid clinic program at San Francisco General Hospital (SFGH).


  • American Heart Association
  • US Food and Drug Administration Endocrine and Metabolic Drug Advisory Committee
  • National Lipid Association

Professional titles

Director of the Gladstone Lipid Clinic, Professor of Medicine, University of California, San Francisco


  • University of Kentucky
  • Vanderbilt University

Honors and Awards

2009 Nutritional Lipid Association Service Award for Past Presidents
2006 Special Recognition Award for Teaching, Service, and Leadership by the Council of Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association
2004 Clinical Mentoring Commendation, UCSF School of Pharmacy
2001 Best Doctors in America